SCHEMBL16185484

SCHEMBL16185484

c1ccc(-c2cc(-c3cccc4oc5ccccc5c34)nc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ NPSR1 Q6W5P4 3/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ AGTR1 P30556 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ HPGD P15428 4/20 0.34
▸ MAPK1 P28482 5/20 0.33
▸ L3MBTL1 Q9Y468 4/20 0.33
▸ PLAUR Q03405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16185392 0.95 MAPT (0.36) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL16185388 0.94 BACE1 (0.38) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL16185477 0.94 ALDH1A1 (0.35) MAPTSMN1; SMN2KMT2AMEN1TDP1
SCHEMBL19239476 0.93 PLA2G2A (0.34) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL16185482 0.93 MAPT (0.35) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL16185431 0.93 MAPT (0.33) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL19769831 0.92 KDM4E (0.38) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL16811486 0.92 CYP1A2 (0.33) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL24848885 0.92 MAPT (0.34) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL19769726 0.92 KDM4E (0.37) MAPTSMN1; SMN2KMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-07-22 — — US disclosed
US-20210119148-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-04-22 — — US disclosed
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-20 — — US disclosed
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2019-03-07 — — US disclosed
US-9847501-B2 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2017-12-19 — — US disclosed
US-9847501-B2 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2017-12-19 — — US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 — — US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 — — US disclosed
US-20140312338-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-10-23 — — US disclosed
US-20140312338-A1 AROMATIC HETEROCYCLIC DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 MAPT 1656/4885SMN1; SMN2 4280/4885KMT2A 1403/4885
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CRY2 MAPT 1656/4885SMN1; SMN2 4280/4885KMT2A 1403/4885
US-20210119148-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 MAPT 1656/4885SMN1; SMN2 4280/4885KMT2A 1403/4885
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 MAPT 1656/4885SMN1; SMN2 4280/4885KMT2A 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback